Questions | Choices |
---|---|
According to your experience, what was changed by the reimbursement of the grass-pollen tablets for seasonal rhinitis? | a. Accessibility to sublingual immunotherapy b. Possibility to adequately treat patients with moderate to severe seasonal rhinitis c. Possibility to treat all ARIA stages of rhinitis d. The concept of AIT as a drug |
According to your opinion, how important is that the content of the allergen extract mirror the patient’s natural exposure? | a. Very important b. Not important c. I do not know |
Which is the treatment schedule for grass pollen-induced rhinitis more oriented toward patient’s preference? | a. Perennial b. Pre-coseasonal c. Indifferent |
According to your experience, the registered sublingual immunotherapy has a tolerability and safety profile | a. Very good b. Good c. Quite low |
In performing sublingual immunotherapy, is the build-up phase important? | a. Yes b. No c. I do not know |
After starting registered sublingual immunotherapy, do you check the patient after some weeks/months? | a. Always b. Sometimes c. Never |